ﺑﺎﺯﮔﺸﺖ ﺑﻪ ﺻﻔﺤﻪ ﻗﺒﻠﯽ
خرید پکیج
تعداد آیتم قابل مشاهده باقیمانده : 3 مورد
نسخه الکترونیک
medimedia.ir

Potential adverse effects of cannabis use

Potential adverse effects of cannabis use
Symptom Other considerations Practical clinical recommendation
Most common[1]
Drowsiness/fatigue
  • Exacerbated by mixing with other sedating medications.[2]
  • Start at a low THC dose and increase slowly when initiating.
  • Reduce THC dose and increase CBD dosing.
  • Do not mix with other sedating medications.
Dizziness  
  • Start at a low THC dose and increase slowly when initiating.[3]
  • Reduce THC dose.
Dry mouth
  • Risk reduced when starting at a low THC dose and increasing slowly.[3]
  • Reduce THC dose.
Anxiety
  • Dose-dependent effect driven by THC; lower THC doses may reduce anxiety, while high doses worsen anxiety.[4] CBD has been shown to reduce anxiety.[5]
  • Start at a low THC dose and increase slowly when initiating.
  • Use a product with more CBD.
Cough, phlegm, bronchitis
  • With inhaled cannabis only.
  • Worsened when inhaled in papers that contain nicotine (eg, cigar papers) or if loose leaf tobacco is added to cannabis due to nicotine/tobacco exposure.
  • Vaporized cannabis may produce fewer toxins than combusted cannabis and be safer.[6]
  • Avoid inhaled cannabis if possible
  • If using inhaled cannabis, vaporized may be safer than combusted.
  • Eliminate any tobacco products coadministered with cannabis.
Nausea  
  • Start at a low THC dose and increase slowly when initiating.
  • Reduce THC dose.
Cognitive effects
  • Resolves after days to weeks of abstinence.
  • Start at a low THC dose and increase slowly when initiating.
  • Reduce THC dose and increase CBD dose.
  • Reduce polypharmacy.
Common[1]
Intoxication
  • Dose dependent and driven by THC.
  • Start at a low THC dose and increase slowly when initiating.
  • Reduce THC dose.
Blurred vision  
  • Start at a low THC dose and increase slowly when initiating.
  • Reduce THC dose.
Headache  
  • Start at a low THC dose and increase slowly when initiating.
  • Reduce THC dose.
Cannabis use disorder
  • Occurs in 8 to 12% of people who use unregulated cannabis for adult-use purposes.[7,8]
  • Initiate/refer for treatment.
  • Discuss harm reduction options.
Rare[1]
Orthostatic hypotension  
  • Start at a low THC dose and increase slowly when initiating.
  • Reduce THC dose and increase CBD dose.
  • Reduce polypharmacy.
Psychosis/paranoia
  • Dose dependent and caused by high doses of THC.
  • Combining THC with CBD associated with less psychosis.
  • Starting at a low THC dose and increasing slowly when initiating reduces the risk of developing psychosis.
  • Reduce THC dose versus cease THC use.
Depression    
Ataxia/dyscoordination  
  • Start at a low THC dose and increase slowly when initiating.
  • Reduce THC dose.
Tachycardia  
  • Start at a low THC dose and increase slowly when initiating.
  • Reduce THC dose.
Cannabis hyperemesis
  • Should be diagnosed using the Venkatesan criteria.[9]
  • Treatment is abstinence from cannabis for months.
  • Clinicians should be aware of and manage symptoms of cannabis withdrawal.
Diarrhea    
THC: tetrahydrocannabinol; CBD: cannabidiol.
References:
  1. MacCallum CA, Russo EB. Practical considerations in medical cannabis administration and dosing. Eur J Intern Med 2018; 49:12.
  2. Echeverria-Villalobos M, Todeschini AB, Stoicea N, et al. Perioperative care of cannabis users: a comprehensive review of pharmacological and anesthetic considerations. J Clin Anesth 2019; 57:41.
  3. Novotna A, Mares J, Ratcliffe S, et al; Sativex Spasticity Study Group. A randomized, double-blind, placebo-controlled, parallel-group, enriched-design study of nabiximols* (Sativex), as add-on therapy, in subjects with refractory spasticity caused by multiple sclerosis. Eur J Neurol 2011; 18:1122.
  4. Childs E, Lutz JA, de Wit H. Dose-related effects of delta-9-THC on emotional responses to acute psychosocial stress. Drug Alcohol Depend 2017; 177:136.
  5. Crippa JA, Derenusson GN, Ferrari TB, et al. Neural basis of anxiolytic effects of cannabidiol (CBD) in generalized social anxiety disorder: a preliminary report. J Psychopharmacol 2011; 25:121.
  6. Hindocha C, Freeman TP, Winstock AR, Lynskey MT. Vaping cannabis (marijuana) has the potential to reduce tobacco smoking in cannabis users. Addiction 2016; 111:375.
  7. Moss HB, Chen CM, Yi HY. Measures of substance consumption among sub- stance users, DSM-IV abusers, and those with DSM-IV dependence disorders in a nationally representative sample. J Stud Alcohol Drugs 2012; 73:820.
  8. Perkonigg A, Goodwin RD, Fiedler A, et al. The natural course of cannabis use, abuse and dependence during the first decades of life. Addiction 2008; 103:439.
  9. Venkatesan T, Levinthal DJ, Li BUK, et al. Role of chronic cannabis use: cyclic vomiting syndrome vs cannabinoid hyperemesis syndrome. Neurogastroenterol Motil 2019; 31:e13606.
Graphic 141070 Version 1.0

آیا می خواهید مدیلیب را به صفحه اصلی خود اضافه کنید؟